DIFFERENTIATION OF BETA-GLUCOCEREBROSIDASE FROM BETA-GLUCOSIDASE IN HUMAN TISSUES USING SODIUM TAUROCHOLATE
DIFFERENTIATION OF BETA-GLUCOCEREBROSIDASE FROM BETA-GLUCOSIDASE IN HUMAN TISSUES USING SODIUM TAUROCHOLATE
复制标题
DOI:
10.1016/0003-9861(76)90547-6
复制
发表时间:
1976-01-01
影响因子:
3.9
通讯作者:
GLEW, RH
中科院分区:
文献类型:
--
作者:
PETERS, SP;COYLE, P;GLEW, RH
Human tissues contain at least 2 enzymes capable of releasing glucose from 4-methylumbelliferyl-.beta.-D-glucopyranoside, but only 2 of these enzymes can hydrolyze glucocerebroside and is deficient in individuals with Gaucher''s disease. In human liver, these 2 .beta.-glucosidases differ in terms of their subcellular localization, chromatographic behavior on ion-exchange columns, substrate specificity and sensitivity to inhibition or activation by sodium taurocholate and phospholipids. When the relatively nonspecific, artificial .beta.-glucoside substrate, 4-methylumbelliferyl-.beta.-D-glucopyranoside, is used under assay conditions optimal for glucocerebroside hydrolysis, it is effective in measuring relative glucocerebroside:.beta.-glucosidase activity and can be used to evaluate an individual''s status with respect to Gaucher''s disease. These conditions of assay require a pH near neutrality (pH 5.5-6.5) and the presence of the detergent sodium taurocholate. The inclusion of sodium taurocholate in assays using 4-methylumbelliferyl-.beta.-D-glucopyranoside as substrate permits the specific measurement of glucocerebroside:.beta.-glucosidase activity because sodium taurocholate inhibits the nonspecific .beta.-glucosidase not involved in Gaucher''s disease and stimulates the relevant .beta.-glucocerebrosidase activity.